SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-003783
Filing Date
2021-11-09
Accepted
2021-11-09 16:46:09
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cala-20210930.htm   iXBRL 10-Q 2556368
2 EX-10.1 cala-ex10_1.htm EX-10.1 167593
3 EX-10.3 cala-ex10_3.htm EX-10.3 792097
4 EX-31.1 cala-ex31_1.htm EX-31.1 15082
5 EX-31.2 cala-ex31_2.htm EX-31.2 14696
6 EX-32.1 cala-ex32_1.htm EX-32.1 10466
7 EX-32.2 cala-ex32_2.htm EX-32.2 10365
  Complete submission text file 0000950170-21-003783.txt   9028332

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cala-20210930_def.xml EX-101.DEF 143605
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cala-20210930_lab.xml EX-101.LAB 405995
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cala-20210930_pre.xml EX-101.PRE 291536
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cala-20210930.xsd EX-101.SCH 49359
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cala-20210930_cal.xml EX-101.CAL 38673
13 EXTRACTED XBRL INSTANCE DOCUMENT cala-20210930_htm.xml XML 1397821
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36644 | Film No.: 211392913
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences